» Articles » PMID: 39979293

Bacteria Invade the Brain Following Intracortical Microelectrode Implantation, Inducing Gut-brain Axis Disruption and Contributing to Reduced Microelectrode Performance

Abstract

Brain-machine interface performance can be affected by neuroinflammatory responses due to blood-brain barrier (BBB) damage following intracortical microelectrode implantation. Recent findings suggest that certain gut bacterial constituents might enter the brain through damaged BBB. Therefore, we hypothesized that damage to the BBB caused by microelectrode implantation could facilitate microbiome entry into the brain. In our study, we found bacterial sequences, including gut-related ones, in the brains of mice with implanted microelectrodes. These sequences changed over time. Mice treated with antibiotics showed a reduced presence of these bacteria and had a different inflammatory response, which temporarily improved microelectrode recording performance. However, long-term antibiotic use worsened performance and disrupted neurodegenerative pathways. Many bacterial sequences found were not present in the gut or in unimplanted brains. Together, the current study established a paradigm-shifting mechanism that may contribute to chronic intracortical microelectrode recording performance and affect overall brain health following intracortical microelectrode implantation.

References
1.
Kim K . Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol. 2008; 6(8):625-34. PMC: 5206914. DOI: 10.1038/nrmicro1952. View

2.
Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M . Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2012; 41(1):e1. PMC: 3592464. DOI: 10.1093/nar/gks808. View

3.
Martinez J, Baquero F . Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother. 2000; 44(7):1771-7. PMC: 89960. DOI: 10.1128/AAC.44.7.1771-1777.2000. View

4.
Rubin D, Bolu Ajiboye A, Barefoot L, Bowker M, Cash S, Chen D . Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System. Neurology. 2023; 100(11):e1177-e1192. PMC: 10074470. DOI: 10.1212/WNL.0000000000201707. View

5.
Vitner E, Dekel H, Zigdon H, Shachar T, Farfel-Becker T, Eilam R . Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Hum Mol Genet. 2010; 19(18):3583-90. DOI: 10.1093/hmg/ddq273. View